drugset / Trial / NCT01983566

Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects

NCT01983566 ↗

Phase 1 Terminated 16 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this trial is to investigate the effect of food with different fat content and of gastric pH increase (mediated by multiple dosing of omeprazole) on the relative bioavailability of deleobuvir.

Timeline

Start
2013-11
Primary completion
2014-01
Completion
2014-01

Outcome

Missed primary endpoint

registry analysis (non-inferiority or equivalence test); Dele Fasted vs Dele Low Fat; p = 0.3944; Geometric mean ratio (%) 115.80 (90% CI 63.52 to 211.11) NCT01983566 ↗

registry P-value for ratio outside interval 80-125%. NCT01983566 ↗

registry analysis (non-inferiority or equivalence test); Dele Fasted vs Dele Low Fat; p = 0.3674; Geometric mean ratio (%) 114.83 (90% CI 74.803 to 176.281) NCT01983566 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Deleobuvir Small molecule — —
Subject Omeprazole Other / unclassified 40 mg —

Indications

No indication recorded.